The CPACS 1a/1b is open label so results are available once first patient data is known although it may be in batches or as the company deems appropriate (unless adverse which should not be withheld). So if it starts later this year we may be lucky with readouts if trial approval and recruitment goes well, but more likely in 2025 for expectations and H1 would be good.
The CPACS 1a/1b is open label so results are available once...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
0.165(11.5%) |
Mkt cap ! $273.4M | |||
| Open | High | Low | Value | Volume |
| $1.46 | $1.61 | $1.46 | $245.3K | 161.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 229 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.63 | 1226 | 1 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |